ENDRA Life Sciences Inc. (NASDAQ:NDRA) has scheduled a conference call for 16th November 2020 at 4:30 PM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.endrainc.com
To participate on the live call, please dial 844-369-8774 U.S. or 862-298-0844 (International)
Earnings Expectation
ENDRA Life Sciences Inc. is reporting third quarter financial results on Monday 16th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, NDRA is expected to report 3Q20 loss of $ 0.17 per share. For the full year, analysts anticipate top line of $ 0.20 million, while looking forward to loss of $ 0.82 per share bottom line.
ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a persons body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding.
